Evidence map›Paper›PMID 37749210›Full record

ReviewNature reviews. Genetics2024

Genomic surveillance for antimicrobial resistance - a One Health perspective.

Steven P Djordjevic, Veronica M Jarocki, Torsten Seemann, Max L Cummins, Anne E Watt, Barbara Drigo, Ethan R Wyrsch, Cameron J Reid, Erica Donner, Benjamin P Howden

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 158 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
158citing papers in PubMed, 2 pooled it
23.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

158 citing papers in PubMed, 2 syntheses or guidelines pooled it, 247 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Evaluation of qPCR for QuantifyingAntibiotics (Basel, Switzerland) · 2026
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

98 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Steven P DjordjevicAustralian Institute for Microbiology and Infection, University of Technology Sydney, Sydney, New South Wales, Australia. steven.djordjevic@uts.edu.au.ORCID http://orcid.org/0000-0001-9301-5372
Veronica M JarockiAustralian Institute for Microbiology and Infection, University of Technology Sydney, Sydney, New South Wales, Australia.ORCID http://orcid.org/0000-0003-1249-0994
Torsten SeemannCentre for Pathogen Genomics, University of Melbourne, Melbourne, Victoria, Australia.
Max L CumminsAustralian Institute for Microbiology and Infection, University of Technology Sydney, Sydney, New South Wales, Australia.ORCID http://orcid.org/0000-0001-9333-7160
Anne E WattMicrobiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, University of Melbourne at the Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0002-3842-0479
Barbara DrigoUniSA STEM, University of South Australia, Adelaide, South Australia, Australia.ORCID http://orcid.org/0000-0002-3301-0470
Ethan R WyrschAustralian Institute for Microbiology and Infection, University of Technology Sydney, Sydney, New South Wales, Australia.ORCID http://orcid.org/0000-0002-5274-6416
Cameron J ReidAustralian Institute for Microbiology and Infection, University of Technology Sydney, Sydney, New South Wales, Australia.
Erica DonnerFuture Industries Institute, University of South Australia, Adelaide, South Australia, Australia.ORCID http://orcid.org/0000-0001-6465-2233
Benjamin P HowdenCentre for Pathogen Genomics, University of Melbourne, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0003-0237-1473
University of Technology Sydney · AUThe University of Melbourne · AUUniversity of South Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance (AMR) - the ability of microorganisms to adapt and survive under diverse chemical selection pressures - is influenced by complex interactions between humans, companion and food-producing animals, wildlife, insects and the environment. To understand and manage the threat posed to health (human, animal, plant and environmental) and security (food and water security and biosecurity), a multifaceted 'One Health' approach to AMR surveillance is required. Genomic technologies have enabled monitoring of the mobilization, persistence and abundance of AMR genes and mutations within and between microbial populations. Their adoption has also allowed source-tracing of AMR pathogens and modelling of AMR evolution and transmission. Here, we highlight recent advances in genomic AMR surveillance and the relative strengths of different technologies for AMR surveillance and research. We showcase recent insights derived from One Health genomic surveillance and consider the challenges to broader adoption both in developed and in lower- and middle-income countries.

Indexed as

Drug Resistance, BacterialOne HealthAnimalsAnimals, WildAnti-Bacterial AgentsGenomicsHumansAnti-Bacterial Agents

Identifiers

PMID37749210
OpenAlexW4387012793

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.